{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:48:30Z","timestamp":1788922110601,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["PID2020\\u2013113938RB-I00"],"award-info":[{"award-number":["PID2020\\u2013113938RB-I00"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["PID2022\\u2013140912OB-I00"],"award-info":[{"award-number":["PID2022\\u2013140912OB-I00"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["PID2023\\u2013146914OB-I00"],"award-info":[{"award-number":["PID2023\\u2013146914OB-I00"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["MCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006433","name":"Barcelona Supercomputing Center","doi-asserted-by":"publisher","award":["RES-BCV-2024\\u20132\\u20130002"],"award-info":[{"award-number":["RES-BCV-2024\\u20132\\u20130002"]}],"id":[{"id":"10.13039\/501100006433","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Department of Health","doi-asserted-by":"publisher","award":["2021-SGR-00230"],"award-info":[{"award-number":["2021-SGR-00230"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["ZIA DA000493"],"award-info":[{"award-number":["ZIA DA000493"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.phrs.2025.107904","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T15:50:15Z","timestamp":1754668215000},"page":"107904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Distinctive biochemical properties of the \u03bc-opioid receptor-corticotropin- releasing factor CRF1 receptor heterotetramer"],"prefix":"10.1016","volume":"219","author":[{"given":"William N.","family":"Sanchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ciruela-Jard\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil","family":"Casajuana-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Yauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning-Sheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Quiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya Gin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicent","family":"Casad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh D.","family":"Plant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.107904_bib1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0278-5846(01)00161-0","article-title":"Role of endogenous opioid system in the regulation of the stress response","volume":"25","author":"Drolet","year":"2001","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107904_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.1091062","article-title":"Neuroscience. Feeling the pain of social loss","volume":"302","author":"Panksepp","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.phrs.2025.107904_bib3","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.pnpbp.2005.08.011","article-title":"Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors","volume":"29","author":"Ribeiro","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107904_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ynstr.2014.09.006","article-title":"Endogenous opioids: the downside of opposing stress","volume":"1","author":"Valentino","year":"2015","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.phrs.2025.107904_bib5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41583-018-0028-x","article-title":"Opioid receptors: drivers to addiction?","volume":"19","author":"Darcq","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2025.107904_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev.pharmtox.44.101802.121410","article-title":"CRF and CRF receptors: role in stress responsivity and other behaviors","volume":"44","author":"Bale","year":"2004","journal-title":"Annu Rev. Pharm. Toxicol."},{"key":"10.1016\/j.phrs.2025.107904_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0014-2999(74)90045-4","article-title":"Noradrenergic neurons: morphine inhibition of spontaneous activity","volume":"25","author":"Korf","year":"1974","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107904_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-3565(24)36621-2","article-title":"Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity","volume":"281","author":"Curtis","year":"1997","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.phrs.2025.107904_bib9","doi-asserted-by":"crossref","first-page":"8193","DOI":"10.1523\/JNEUROSCI.1657-04.2004","article-title":"Chronic morphine sensitizes the brain norepinephrine system to corticotropin-releasing factor and stress","volume":"24","author":"Xu","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107904_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuroscience.2005.02.004","article-title":"Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons","volume":"133","author":"Zhu","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2025.107904_bib11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuropharm.2013.02.014","article-title":"Corticotropin releasing factor and catecholamines enhance glutamatergic neurotransmission in the lateral subdivision of the central amygdala","volume":"70","author":"Silberman","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107904_bib12","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.neuropharm.2017.08.009","article-title":"CRF modulates glutamate transmission in the central amygdala of na\u00efve and ethanol-dependent rats","volume":"125","author":"Varodayan","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107904_bib13","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0087-19.2019","article-title":"Molecular, morphological, and functional characterization of corticotropin-releasing factor receptor 1-expressing neurons in the central nucleus of the amygdala","volume":"6","author":"Wolfe","year":"2019","journal-title":"eNeuro"},{"key":"10.1016\/j.phrs.2025.107904_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/bph.14877","article-title":"Opioids differentially modulate two synapses important for pain processing in the amygdala","volume":"177","author":"Kissiwaa","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2025.107904_bib15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jphs.2024.02.004","article-title":"Presynaptic inhibition of excitatory synaptic transmission from the calcitonin gene-related peptide-containing parabrachial neurons to the central amygdala in mice - unexpected influence of systemic inflammation thereon","volume":"154","author":"Sato","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.phrs.2025.107904_bib16","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1172\/JCI126912","article-title":"Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids","volume":"129","author":"Cai","year":"2019","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2025.107904_bib17","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1523\/JNEUROSCI.2442-16.2016","article-title":"Functional mu-Opioid-Galanin receptor heteromers in the ventral tegmental area","volume":"37","author":"Moreno","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107904_bib18","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41380-023-02353-z","article-title":"Unique pharmacodynamic properties and low abuse liability of the \u00b5-opioid receptor ligand (S)-methadone","volume":"29","author":"Levinstein","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107904_bib19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41398-023-02473-8","article-title":"The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users","volume":"13","author":"Shram","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107904_bib20","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.24m15438","article-title":"Long-Term safety and efficacy of esmethadone in patients with major depressive disorder: findings from a 12-Month Open-Label study","volume":"86","author":"Fava","year":"2025","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.phrs.2025.107904_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106322","article-title":"Preferential gs protein coupling of the galanin Gal1 receptor in the micro-opioid-Gal1 receptor heterotetramer","volume":"182","author":"De Oliveira","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2025.107904_bib22","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/s41467-018-03522-3","article-title":"Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase","volume":"9","author":"Navarro","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107904_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107977","article-title":"G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs)","volume":"231","author":"Ferre","year":"2022","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.phrs.2025.107904_bib24","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nchembio.623","article-title":"CODA-RET reveals functional selectivity as a result of GPCR heteromerization","volume":"7","author":"Urizar","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.phrs.2025.107904_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12915-018-0491-x","article-title":"Cross-communication between gi and gs in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain","volume":"16","author":"Navarro","year":"2018","journal-title":"BMC Biol."},{"key":"10.1016\/j.phrs.2025.107904_bib26","doi-asserted-by":"crossref","first-page":"16916","DOI":"10.1073\/pnas.0704257104","article-title":"Quantification of dynamic protein complexes using renilla luciferase fragment complementation applied to protein kinase a activities in vivo","volume":"104","author":"Stefan","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2025.107904_bib27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1083\/jcb.201009128","article-title":"Full characterization of GPCR monomer\u2013dimer dynamic equilibrium by single molecule imaging","volume":"192","author":"Kasai","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.phrs.2025.107904_bib28","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1007\/s00018-021-03761-6","article-title":"Structure and function of adenosine receptor heteromers","volume":"78","author":"Franco","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.phrs.2025.107904_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12915-020-0739-0","article-title":"Control of glutamate release by complexes of adenosine and cannabinoid receptors","volume":"18","author":"Kofalvi","year":"2020","journal-title":"BMC Biol."},{"key":"10.1016\/j.phrs.2025.107904_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuron.2010.12.001","article-title":"Facilitation of \u03bc-opioid receptor activity by preventing \u03b4-opioid receptor-mediated codegradation","volume":"69","author":"He","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2025.107904_bib31","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.phrs.2025.107904_bib32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nsmb.2504","article-title":"Crystal structure of oligomeric \u03b21-adrenergic g protein-coupled receptors in ligand-free basal state","volume":"20","author":"Huang","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.phrs.2025.107904_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature10954","article-title":"Crystal structure of the \u00b5-opioid receptor bound to a morphinan antagonist","volume":"485","author":"Manglik","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107904_bib34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41586-018-0219-7","article-title":"Structure of the \u00b5-opioid receptor\u2013Gi protein complex","volume":"558","author":"Koehl","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107904_bib35","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/s12276-023-01082-1","article-title":"Structure-based drug discovery of a corticotropin-releasing hormone receptor 1 antagonist using an X-ray free-electron laser","volume":"55","author":"Kim","year":"2023","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.phrs.2025.107904_bib36","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.molcel.2020.01.012","article-title":"Toward a structural understanding of class b GPCR peptide binding and activation","volume":"77","author":"Liang","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2025.107904_bib37","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2216230120","article-title":"Structures of human gastrin-releasing peptide receptors bound to antagonist and agonist for cancer and itch therapy","volume":"120","author":"Peng","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107904_bib38","doi-asserted-by":"crossref","first-page":"D395","DOI":"10.1093\/nar\/gkac1013","article-title":"GPCRdb in 2023: state-specific structure models using AlphaFold2 and new ligand resources","volume":"51","author":"P\u00e1ndy-Szekeres","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2025.107904_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107904_bib40","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","article-title":"AmberTools","volume":"63","author":"Case","year":"2023","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/j.phrs.2025.107904_bib41","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1021\/acs.jcim.9b00269","article-title":"PACKMOL-memgen: a simple-to-use, generalized workflow for membrane-protein\u2013lipid-bilayer system building","volume":"59","author":"Schott-Verdugo","year":"2019","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/j.phrs.2025.107904_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","author":"Abraham","year":"2015","journal-title":"SoftwareX 12"},{"key":"10.1016\/j.phrs.2025.107904_bib43","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/jcc.21787","article-title":"MDAnalysis: a toolkit for the analysis of molecular dynamics simulations","volume":"32","author":"Michaud-Agrawal","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.phrs.2025.107904_bib44","doi-asserted-by":"crossref","unstructured":"R. Gowers, M. Linke, J. Barnoud, T. Reddy, M. Melo, S. Seyler, J. Doma\u0144ski, D. Dotson, S. Buchoux, I. Kenney, O. Beckstein, MDAnalysis: A Python Package for the Rapid Analysis of Molecular Dynamics Simulations, in: Austin, Texas, 2016: pp. 98\u2013105. https:\/\/doi.org\/10.25080\/Majora-629e541a-00e.","DOI":"10.25080\/Majora-629e541a-00e"},{"key":"10.1016\/j.phrs.2025.107904_bib45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1021\/acs.jmedchem.4c01796","article-title":"Design of small Non-Peptidic ligands that alter heteromerization between cannabinoid CB1 and serotonin 5HT2A receptors","volume":"68","author":"Matsoukas","year":"2025","journal-title":"J. Med Chem."},{"key":"10.1016\/j.phrs.2025.107904_bib46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2014.11.001","article-title":"Generic GPCR residue numbers - aligning topology maps while minding the gaps","volume":"36","author":"Isberg","year":"2015","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.phrs.2025.107904_bib47","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature22394","article-title":"Cryo-EM structure of the activated GLP-1 receptor in complex with a g protein","volume":"546","author":"Zhang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107904_bib48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1152\/physrev.2001.81.1.299","article-title":"Cellular and synaptic adaptations mediating opioid dependence","volume":"81","author":"Williams","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2025.107904_bib49","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1124\/mol.108.050427","article-title":"Molecular mechanisms of corticotropin-releasing factor Receptor-Induced calcium signaling","volume":"75","author":"Gutknecht","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2025.107904_bib50","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev-pharmtox-011613-135952","article-title":"G Protein\u2013Coupled receptor heteromers","volume":"56","author":"Gomes","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.phrs.2025.107904_bib51","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/pr.113.008052","article-title":"G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives","volume":"66","author":"Ferre","year":"2014","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.phrs.2025.107904_bib52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tips.2015.01.002","article-title":"The GPCR heterotetramer: challenging classical pharmacology","volume":"36","author":"Ferre","year":"2015","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.phrs.2025.107904_bib53","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1007\/s12035-019-1564-8","article-title":"Biased g Protein-Independent signaling of dopamine D1-D3 receptor heteromers in the nucleus accumbens","volume":"56","author":"Guitart","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107904_bib54","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s12035-018-1120-y","article-title":"Adenosine A1-Dopamine D1 receptor heteromers control the excitability of the spinal motoneuron","volume":"56","author":"Rivera-Oliver","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107904_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/bs.irn.2015.06.001","article-title":"The roles of G\u03b2\u03b3 and G\u03b1 in gating and regulation of GIRK channels","volume":"123","author":"Dascal","year":"2015","journal-title":"Int Rev. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107904_bib56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/325321a0","article-title":"The beta gamma subunits of GTP-binding proteins activate the muscarinic K+ channel in heart","volume":"325","author":"Logothetis","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107904_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.irn.2015.05.013","article-title":"Unifying mechanism of controlling Kir3 channel activity by g proteins and phosphoinositides","volume":"123","author":"Logothetis","year":"2015","journal-title":"Int Rev. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107904_bib58","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.neuron.2006.08.017","article-title":"GIRK channel activation involves a local rearrangement of a preformed g protein channel complex","volume":"51","author":"Riven","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2025.107904_bib59","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60552","article-title":"Cryo-EM analysis of PIP2 regulation in mammalian GIRK channels","volume":"9","author":"Niu","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.phrs.2025.107904_bib60","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/jcp.30535","article-title":"Roles of PLC\u03b2, PIP2, and GIRK channels in arginine vasopressin-elicited excitation of CA1 pyramidal neurons","volume":"237","author":"Hu","year":"2022","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.phrs.2025.107904_bib61","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1085\/jgp.114.5.673","article-title":"Synergistic activation of g protein-gated inwardly rectifying potassium channels by the betagamma subunits of g proteins and Na(+) and Mg(2+) ions","volume":"114","author":"Petit-Jacques","year":"1999","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.phrs.2025.107904_bib62","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/35882","article-title":"Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by gbetagamma","volume":"391","author":"Huang","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.107904_bib63","doi-asserted-by":"crossref","first-page":"PL339","DOI":"10.1016\/0024-3205(94)90022-1","article-title":"Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence","volume":"54","author":"Wang","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2025.107904_bib64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.npp.1300782","article-title":"Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice","volume":"31","author":"Shoblock","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2025.107904_bib65","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1239403","article-title":"Constitutive \u03bc-opioid receptor activity leads to long-term endogenous analgesia and dependence","volume":"341","author":"Corder","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.phrs.2025.107904_bib66","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuroscience.2018.03.024","article-title":"Corticotropin-Releasing factor in the brain and blocking spinal descending signals induce hyperalgesia in the latent sensitization model of chronic pain","volume":"381","author":"Chen","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2025.107904_bib67","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jnr.24846","article-title":"Endogenous \u00b5-opioid receptor activity in the lateral and capsular subdivisions of the right central nucleus of the amygdala prevents chronic postoperative pain","volume":"100","author":"Cooper","year":"2022","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.phrs.2025.107904_bib68","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.neuroscience.2008.12.061","article-title":"Mu-opioid and corticotropin-releasing-factor receptors show largely postsynaptic co-expression, and separate presynaptic distributions, in the mouse central amygdala and bed nucleus of the stria terminalis","volume":"159","author":"Jaferi","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2025.107904_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108052","article-title":"Amygdala, neuropeptides, and chronic pain-related affective behaviors","volume":"170","author":"Neugebauer","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2025.107904_bib70","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/aja.1001650404","article-title":"Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain","volume":"165","author":"Merchenthaler","year":"1982","journal-title":"Am. J. Anat."},{"key":"10.1016\/j.phrs.2025.107904_bib71","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0006-8993(99)01168-3","article-title":"Localization of mu-opioid receptors on amygdaloid projection neurons in the parabrachial nucleus of the rat","volume":"827","author":"Chamberlin","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2025.107904_bib72","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U","article-title":"Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse","volume":"428","author":"Van Pett","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.phrs.2025.107904_bib73","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/cne.21848","article-title":"Type 1 corticotropin-releasing factor receptor expression reported in BAC transgenic mice: implications for reconciling ligand-receptor mismatch in the central corticotropin-releasing factor system","volume":"511","author":"Justice","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.phrs.2025.107904_bib74","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.tins.2024.07.002","article-title":"Parabrachial neurons promote nociplastic pain","volume":"47","author":"Palmiter","year":"2024","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2025.107904_bib75","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/cne.25136","article-title":"Efferent projections of CGRP\/calca-expressing parabrachial neurons in mice","volume":"529","author":"Huang","year":"2021","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.phrs.2025.107904_bib76","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1476-5381.2012.02202.x","article-title":"Receptor activity modifying proteins (RAMPs) interact with theVPAC2receptor andCRF1receptors and modulate their function","volume":"168","author":"Wootten","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2025.107904_bib77","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bbamem.2019.02.008","article-title":"Interactions between RAMP2 and CRF receptors: the effect of receptor subtypes, splice variants and cell context","volume":"1861","author":"Bailey","year":"2019","journal-title":"Biochim. Et. Biophys. Acta (BBA) Biomembr."},{"key":"10.1016\/j.phrs.2025.107904_bib78","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/bs.apha.2020.01.001","article-title":"RAMPs as allosteric modulators of the calcitonin and calcitonin-like class b g protein-coupled receptors","volume":"88","author":"Pioszak","year":"2020","journal-title":"Adv. Pharm."},{"key":"10.1016\/j.phrs.2025.107904_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12755-9","article-title":"Minute-scale persistence of a GPCR conformation state triggered by non-cognate g protein interactions primes signaling","volume":"10","author":"Gupte","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107904_bib80","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1124\/molpharm.122.000541","article-title":"Coincident regulation of PLC\u03b2 signaling by Gq-Coupled and \u03bc-Opioid receptors opposes Opioid-mediated antinociception","volume":"102","author":"Sanchez","year":"2022","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2025.107904_bib81","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1002\/anie.201912683","article-title":"Selective and wash-resistant fluorescent dihydrocodeinone derivatives allow single-molecule imaging of \u03bc-Opioid receptor dimerization","volume":"59","author":"Gentzsch","year":"2020","journal-title":"Angew. Chem. Int Ed."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:48:10Z","timestamp":1772880490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825003299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":81,"alternative-id":["S1043661825003299"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107904","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinctive biochemical properties of the \u03bc-opioid receptor-corticotropin- releasing factor CRF1 receptor heterotetramer","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107904"}}